Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gold-induced aplastic anemia.

L M Williame1, R Joos, F Proot

  • 1Department of Rheumatology, Algemeen Ziekenhuis Middelheim, Antwerpen, Belgium.

Clinical Rheumatology
|December 1, 1987
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnositic value of pelvic enthesitis on MRI of the sacroiliac joints in enthesitis related arthritis.

Pediatric rheumatology online journal·2015
Same author

Diagnostic value of MRI features of sacroiliitis in juvenile spondyloarthritis.

Clinical radiology·2015
Same author

Methotrexate in combination with other DMARDs is not superior to methotrexate alone for remission induction with moderate-to-high-dose glucocorticoid bridging in early rheumatoid arthritis after 16 weeks of treatment: the CareRA trial.

Annals of the rheumatic diseases·2014
Same author

Sensitivity and specificity of criteria for spondyloarthritis in children with late onset pauciarticular juvenile chronic arthritis as well as their characteristics.

Clinical and experimental rheumatology·2009
Same author

Juvenile-onset systemic lupus erythematosus: different clinical and serological pattern than adult-onset systemic lupus erythematosus.

Annals of the rheumatic diseases·2008
Same author

Expressive dimensions of pain catastrophizing: a comparative analysis of school children and children with clinical pain.

Pain·2007
Same journal

Elevated serum IgG1, complement activation, and clinical severity in IgG4-related disease: a comprehensive subgroup analysis.

Clinical rheumatology·2026
Same journal

AI-based CT quantification reveals small airway loss and vascular simplification in rheumatoid arthritis-associated lung disease.

Clinical rheumatology·2026
Same journal

Association between Modified Cardiometabolic Index and rheumatoid arthritis: the mediating role of phenotypic age acceleration.

Clinical rheumatology·2026
Same journal

Human epididymis protein 4: a potential prognostic biomarker for rheumatoid arthritis-associated interstitial lung disease.

Clinical rheumatology·2026
Same journal

Cutaneous lesions with Cryptococcus-like changes in the context of ANCA vasculitis: case reports and literature review.

Clinical rheumatology·2026
Same journal

A pilot educational intervention to improve knowledge and readiness for self-management among patients with rheumatic diseases in Uganda.

Clinical rheumatology·2026
See all related articles

Gold salts can cause severe aplastic anemia in rheumatoid arthritis patients, particularly sero-negative women. Close blood monitoring is crucial for early detection of myelotoxicity.

Area of Science:

  • Rheumatology
  • Hematology
  • Pharmacology

Background:

  • Rheumatoid arthritis (RA) is a chronic autoimmune disease.
  • Gold salts are a class of disease-modifying antirheumatic drugs (DMARDs).

Observation:

  • Three RA patients on gold salt therapy developed severe aplastic anemia.
  • Disease remission coincided with the onset of marrow aplasia.

Findings:

  • Fatal aplastic anemia appears more common in sero-negative women responding well to gold salts.
  • Myelotoxicity may be signaled by subtle drops in blood cell counts.
  • All three patients died from septic shock despite treatment.

Implications:

  • Enhanced vigilance and blood monitoring are essential for patients on gold salt therapy.

Related Experiment Videos

  • Early detection of myelotoxicity may improve patient outcomes.
  • Consider alternative treatments for sero-negative women with RA who respond well to gold salts.